Related Experiment Video

Updated: Sep 25, 2026

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
05:31

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

Published on: January 26, 2024

Cerebrovascular Disease in Pregnancy

Salina Waddy1, Barney J. Stern

  • 1Department of Neurology.

Current Treatment Options in Cardiovascular Medicine
|June 5, 2003
PubMed

Insights

Diagnosing cerebrovascular disease in pregnancy is challenging. Treatment for pregnant patients with stroke involves antithrombotic agents, with specific recommendations for cryptogenic or identified etiologies, and cautious use of warfarin.

Area of Science:

  • Neurology
  • Obstetrics
  • Hematology

Background:

  • Cerebrovascular disease during pregnancy presents diagnostic and therapeutic challenges.
  • Fetal toxicity from diagnostic tests and treatments is a significant concern.
  • Identifying the precise cause of stroke in pregnant individuals is crucial for effective management.

Purpose of the Study:

  • To outline evidence-based therapeutic strategies for cerebrovascular events in pregnancy.
  • To provide guidance on anticoagulant selection and timing during pregnancy.

Main Methods:

  • Review of current literature and clinical guidelines for managing stroke in pregnancy.
  • Analysis of anticoagulant properties and safety profiles relevant to obstetric patients.

Main Results:

  • For cryptogenic arterial ischemic events, low-dose aspirin or other antithrombotics are recommended.
  • Specific etiologies warrant unfractionated heparin or low molecular weight heparin.
  • Warfarin use is restricted to specific situations (e.g., heparin-induced thrombocytopenia) and limited to the second and third trimesters, post-organogenesis.

Conclusions:

  • Tailored anticoagulant therapy is essential for managing cerebrovascular disease in pregnancy.
  • Anticoagulant choice depends on the stroke's etiology and gestational stage.
  • Alternating heparin and warfarin regimens are generally impractical due to difficulties in maintaining consistent anticoagulation.

More Related Videos

Assessment of Maternal Vascular Remodeling During Pregnancy in the Mouse Uterus06:55

Assessment of Maternal Vascular Remodeling During Pregnancy in the Mouse Uterus

Published on: December 5, 2015

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

Related Concept Videos

Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...
Cerebral Edema l: Introduction01:19

Cerebral Edema l: Introduction

Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...